KORYN MICHAUD: Open Payments
NPI 1750781316 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$837 in 31 payments from 9 companies in 2025. Trend: 2023 $83 · 2024 $306 · 2025 $837
Food & beverage: $837
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $303 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $244 |
| Indivior Inc. | 5 | $139 |
| ABBVIE INC. | 2 | $34 |
| JAZZ PHARMACEUTICALS INC. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Braeburn Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $18 |
Products named: UZEDY, CAPLYTA, SUBLOCADE, REXULTI, XYWAV, INGREZZA, BRIXADI, QULIPTA.
Industry payments across NM — which companies pay providers there.
